Typical absence seizures and their treatment

Archives of Disease in Childhood

Volumn 81, Issue 4, 1999, Pages 351-355

  Panayiotopoulos, C P ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETHOSUXIMIDE; LAMOTRIGINE; TIAGABINE; VALPROIC ACID; VIGABATRIN;

ANTICONVULSANT THERAPY; DIFFERENTIAL DIAGNOSIS; ELECTROENCEPHALOGRAM; HUMAN; PRIORITY JOURNAL; REVIEW; SEIZURE; TREATMENT INDICATION;

EID: 0032860017     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.81.4.351     Document Type: Review

References (25)

1. Commission of Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501.
2. Marescaux C, Vergnes M. Animal models of absence seizures and absence epilepsies. In: Duncan JS, Panayiotopoulos CP, eds. Typical absences and related epileptic syndromes. London: Churchill Communications Europe, 1995:8-18.
3. Futatsugi Y, Riviello JJ, Jr. Mechanisms of generalised absence epilepsy. Brain Dev 1998;20:75-9.
4. Danober L, Deransart C, Depaulis A, Vergnes M, Marescaux C. Pathophysiological mechanisms of genetic absence epilepsy in the rat. Prog Neurobiol 1998;55:27-57.
5. Coulter DA. Antiepileptic drug cellular mechanisms of action: where does lamotrigine fit in? J Child Neurol 1997; 12(suppl 1):S2-9.
6. Panayiotopoulos CP. Absence epilepsies. In: Engel JJ, Pedley TA, eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven Publishers, 1997;2327-46.
7. Parker AP, Agathonikou A, Robinson RO, Panayiotopoulos CP. Inappropriate use of carbamazepine and vigabatrin in typical absence seizures. Dev Med Child Neurol 1998;40:517-19.
8. Lombroso CT. Consistent EEG focalities detected in subjects with primary generalised epilepsies monitored for two decades. Epilepsia 1997;38:797-812.
9. Panayiotopoulos CP. Benign childhood partial seizures and related epileptic syndromes. London: John Libbey and Company, 1999.
10. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
11. Panayiotopoulos CP, Koutroumanidis M, Giannakodimos S, Agathonikou A. Idiopathic generalised epilepsy in adults manifested by phantom absences, generalised tonic-clonic seizures, and frequent absence status. J Neural Neurosurg Psychiatry 1997;63:622-7.
12. Ferrie CD, Giannakodìmos S, Robinson RO, Panayiotopoulos CP. Symptomatic typical absence seizures. In: Duncan JS, Panayiotopoulos CP, eds. Typical absences and related epileptic syndromes. London: Churchill Communications Europe, 1995:241-52.
13. Panayiotopoulos CP, Agathonikou A, Sharoqi IA, Parker AP. Vigabatrin aggravates absences and absence status. Neurology 1997;49:1467.
14. Schapel G, Chadwick D. Tiagabine and non-convulsive status epilepticus. Seizure 1996;5:153-6.
15. Richens A. Ethosuximide and valproate. In: Duncan JS, Panayiotopoulos CP, eds. Typical absences and related epileptic syndromes. London: Churchill Communications Europe, 1995:361-7.
16. Panayiotopoulos CP, Ferrie CD, Knott C, Robinson RO. Interaction of lamotrigine with sodium valproate. Lancet 1993;341:145.
17. Ferrie CD, Robinson RO, Knott C, Panayiotopoulos CP. Lamotrigine as an add-on drug in typical absence seizures. Acta Neurol Scand 1995;91:200-2.
18. van Rijn CM, Weyn Banningh EW, Coenen AM. Effects of lamotrigine on absence seizures in rats. Pol J Pharmacol 1994;46:167-70.
19. Hosford DA, Wang Y. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures. Epilepsia 1997;38:408-14.
20. Gram L. Acetazolamide, benzodiazepines and lamotrigine. In: Duncan JS, Panayiotopoulos CP, eds. Typical absences and related epileptic syndromes. London: Churchill Europe Communications, 1995:368-75.
21. Livingston J. Status epilepticus. In: Wallace S, ed. Epilepsy in children. London; Chapman and Hall Medical, 1996:429-48.
22. Agathonikou A, Panayiotopoulos CP, Giannakodimos S, Koutroumanidis M. Typical absence status in adults: diagnostic and syndromic considerations. Epilepsia 1998;39:1265-76.
23. Trevathan E, Murphy CC, Yeargin-Allsopp M, et al. Prevalence and descriptive epidemiology of Lennox-Gastaut syndrome among Atlanta children. Buccal absorption of midazolam: pharmacokinetics and EHG pharmacodynamics. Epilepsia 1998;39:290-4.
24. Scott RC, Besag FM, Neville BG. Buccal midazolam and rectal diazepam fur treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet 1999;353:623-6.
25. Frank LM, Enlow T, Holmes GL, et al. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia 1990;40:973-9.